Alnylam Pharmaceuticals, Inc. (ALNY) Earnings
NASDAQ·Healthcare·Biotechnology
$283.35
-2.09%
Mkt Cap $40.46B
EPS — Estimate vs Actual
Mkt Cap
$40.46B
P/E
67.30
Fwd P/E
40.44
P/S
9.44
Rev TTM
—
EPS TTM
$4.21
NASDAQ·Healthcare·Biotechnology
$283.35
-2.09%
Mkt Cap $40.46B
Mkt Cap
$40.46B
P/E
67.30
Fwd P/E
40.44
P/S
9.44
Rev TTM
—
EPS TTM
$4.21